AIM: The purpose of this study was to develop a new orally delivered nanoparticulate system to improve the bioavailability of salmon calcitonin (sCT). MATERIALS & METHODS: Four sCT-loaded solid lipid nanoparticles (SLNs) were prepared successfully by micelle-double emulsion technique via either the sole use of stearic acid (SA) or the combined use of SA and triglycerides (including tripalmitin [TP], trimyristin or trilaurin). RESULTS: Compared with other SLNs, the combination of SA and TP could not only significantly improve the colloidal stability of SLNs and enhance the drug stability in the simulated intestinal fluids, but also intensively increase the intracellular uptake of drugs compared with the other SLNs (p < 0.05). The mechanism of internalization was an active transport involved in clathrin- and caveolae-dependent endocytosis. In vivo, the sCT SLNs prepared with SA and TP exhibited the highest reduction of plasma Ca(2+) level (17.44 ± 3.68%) with a bioavailability of 13.01 ± 3.24%. CONCLUSION: The SLNs formed by SA and TP as the solid lipids may be a promising carrier for oral delivery of peptide drugs.
AIM: The purpose of this study was to develop a new orally delivered nanoparticulate system to improve the bioavailability of salmon calcitonin (sCT). MATERIALS & METHODS: Four sCT-loaded solid lipid nanoparticles (SLNs) were prepared successfully by micelle-double emulsion technique via either the sole use of stearic acid (SA) or the combined use of SA and triglycerides (including tripalmitin [TP], trimyristin or trilaurin). RESULTS: Compared with other SLNs, the combination of SA and TP could not only significantly improve the colloidal stability of SLNs and enhance the drug stability in the simulated intestinal fluids, but also intensively increase the intracellular uptake of drugs compared with the other SLNs (p < 0.05). The mechanism of internalization was an active transport involved in clathrin- and caveolae-dependent endocytosis. In vivo, the sCT SLNs prepared with SA and TP exhibited the highest reduction of plasma Ca(2+) level (17.44 ± 3.68%) with a bioavailability of 13.01 ± 3.24%. CONCLUSION: The SLNs formed by SA and TP as the solid lipids may be a promising carrier for oral delivery of peptide drugs.
Authors: Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker Journal: AAPS J Date: 2014-11-15 Impact factor: 4.009
Authors: Hao Cheng; Aditya Chawla; Yafeng Yang; Yuxiao Li; Jin Zhang; Hae Lin Jang; Ali Khademhosseini Journal: Drug Discov Today Date: 2017-05-06 Impact factor: 7.851
Authors: Sara S Marques; Inês I Ramos; Sara R Fernandes; Luisa Barreiros; Sofia A C Lima; Salette Reis; M Rosário M Domingues; Marcela A Segundo Journal: Molecules Date: 2020-04-18 Impact factor: 4.411
Authors: Irene Santalices; Carlos Vázquez-Vázquez; Manuel J Santander-Ortega; Victoria Lozano; Francisca Araújo; Bruno Sarmento; Neha Shrestha; Veronique Préat; Miguel Chenlo; Clara V Alvarez; Federico Benetti; Juan Cuñarro; Sulay Tovar; Dolores Torres; María José Alonso Journal: Drug Deliv Transl Res Date: 2021-02-11 Impact factor: 4.617